Clinical Trials
9 trialsNCT07617727 2026-06-01
A Phase I Study of JSKN021 in Advanced Solid Tumors
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Phase 1 Not yet recruiting
NCT07480733 2026-05-29
Phase II Study of JS212/JS213 as Monotherapy and in Combination in Patients With Advanced Malignant Solid Tumors
Shanghai Junshi Bioscience Co., Ltd.
Phase 2 Recruiting
NCT06573294 2026-05-20
Trial to Assess the Safety and Antitumor Activity of GEN1057 in Malignant Solid Tumors
Genmab
Phase 1 Terminated
NCT07566247 2026-05-05
A Phase I Clinical Study of AK150 in Advanced Malignant Solid Tumor
Akeso
Phase 1 Not yet recruiting
NCT06499350 2026-03-10
A Study of FC084CSA in Combination of Tislelizumab in Patients With Advanced Malignant Solid Tumors
FindCure Biosciences (ZhongShan) Co., Ltd.
Phase 1/2 Recruiting
NCT07363369 2026-01-23
Exploratory Clinical Study of FAP mRNA Vaccine in Patients With Advanced Malignant Solid Tumors
West China Hospital
Phase 1 Not yet recruiting
NCT07292402 2025-12-23
JSKN022 in Subjects With Advanced Malignant Solid Tumors
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Phase 1 Recruiting
NCT06231550 2025-08-07
A Study of Axl Inhibitor FC084CSA in Patients With Advanced Malignant Solid Tumors
FindCure Biosciences (ZhongShan) Co., Ltd.
Phase 1 Completed
NCT05383703 2025-07-02
MNC-168
Moon (Guangzhou) Biotechnology Co., Ltd.
Phase 1 Completed